secwatch / observer
8-K filed March 6, 2024, 6:59 PM ET ticker SCNX CIK 0001382574
dividend confidence high sentiment positive materiality 0.90

Scienture Holdings, Inc. (SCNX): M&A transaction — TRxADE Health declares $8 special dividend from asset sale proceeds

Scienture Holdings, Inc.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Scienture Holdings, Inc. completed a disposition involving Superlatus Foods Inc. for $1.00 (closed 2024-03-05).

Action
disposition
Counterparty
Superlatus Foods Inc.
Consideration
$1.00
Closing
2024-03-05
Exact text from the filing
arch 5, 2024, the Company entered in a Stock Purchase Agreement (“SPA”) with Superlatus Foods Inc. (the “Buyer”). Pursuant to the SPA, the Company sold all of the issued and outstanding stock (the “Stock”) of Superlatus Inc., a Delaware
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Scienture Holdings, Inc. entered into Subscription Agreement with Lafayette Energy Corp. valued at up to $5.0 million (effective 2024-02-29).

Action
entry
Agreement
equity purchase
Counterparty
Lafayette Energy Corp.
Value
up to $5.0 million
Effective
2024-02-29
Exact text from the filing
On February 29, 2024, the Company’s wholly owned subsidiary Trxade, Inc. entered into a Subscription Agreement (the “Subscription Agreement”) with Lafayette Energy Corp., a Delaware corporation (“Lafayette”). Pursuant to the Subscription Agreement, Trxade, Inc. will, in two equal tranches, invest a total of up to $5.0 million in Lafayette in exchange for up to 2,000,000 shares of Lafayette’s newly created Series A Convertible Preferred Stock
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Scienture Holdings, Inc. entered into Stock Purchase Agreement with Superlatus Foods Inc. valued at $1.00 (effective 2024-03-05).

Action
entry
Agreement
asset purchase
Counterparty
Superlatus Foods Inc.
Value
$1.00
Effective
2024-03-05
Exact text from the filing
On March 5, 2024, the Company entered in a Stock Purchase Agreement (“SPA”) with Superlatus Foods Inc. (the “Buyer”). Pursuant to the SPA, the Company sold all of the issued and outstanding stock (the “Stock”) of Superlatus Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“Superlatus”), to the Buyer. The purchase price for the Stock was $1.00
View on SEC.gov

74 m&a transactions filed in the last 30 days. Browse all m&a transactions →

Scienture Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-24-008947
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.